J M Cayuela - JoVE Visualize

Showing results (41-50 of 53) with videos related to

Pageof 6

Sort By:

Leukemia|February 1, 2012

Prognostic significance of DNA methyltransferase 3A mutations in cytogenetically normal acute myeloid leukemia: a study by the Acute Leukemia French AssociationA Renneville, N Boissel, O Nibourel, et al.

Leukemia|May 13, 2005

Prognostic implication of FLT3 and Ras gene mutations in patients with acute promyelocytic leukemia (APL): a retrospective study from the European APL GroupC Callens, S Chevret, J-M Cayuela, et al.

Leukemia|October 17, 2003

Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - a Europe Against Cancer programJ Gabert, E Beillard, V H J van der Velden, et al.

Leukemia|February 9, 2007

Analysis of minimal residual disease by Ig/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR dataV H J van der Velden, G Cazzaniga, A Schrauder, et al.

Leukemia|September 26, 2013

An intragenic ERG deletion is a marker of an oncogenic subtype of B-cell precursor acute lymphoblastic leukemia with a favorable outcome despite frequent IKZF1 deletionsE Clappier, M F Auclerc, J Rapion, et al.

Leukemia|October 14, 2006

Allogeneic stem cell transplantation improves the outcome of adults with t(1;19)/E2A-PBX1 and t(4;11)/MLL-AF4 positive B-cell acute lymphoblastic leukemia: results of the prospective multicenter LALA-94 studyN Vey, X Thomas, C Picard, et al.

Leukemia|July 10, 2009

PAX5 mutations occur frequently in adult B-cell progenitor acute lymphoblastic leukemia and PAX5 haploinsufficiency is associated with BCR-ABL1 and TCF3-PBX1 fusion genes: a GRAALL studyJ Familiades, M Bousquet, M Lafage-Pochitaloff, et al.

Leukemia|May 4, 2007

Characterization of a reference material for BCR-ABL (M-BCR) mRNA quantitation by real-time amplification assays: towards new standards for gene expression measurementsJ Saldanha, M Silvy, N Beaufils, et al.

Leukemia|March 13, 2019

Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph + ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1H Pfeifer, G Cazzaniga, V H J van der Velden, et al.

Leukemia|January 16, 2020

Correction: Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1H Pfeifer, G Cazzaniga, V H J van der Velden, et al.

Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:

Pageof 6

Leukemia|February 1, 2012

Prognostic significance of DNA methyltransferase 3A mutations in cytogenetically normal acute myeloid leukemia: a study by the Acute Leukemia French AssociationA Renneville, N Boissel, O Nibourel, et al.

Leukemia|May 13, 2005

Prognostic implication of FLT3 and Ras gene mutations in patients with acute promyelocytic leukemia (APL): a retrospective study from the European APL GroupC Callens, S Chevret, J-M Cayuela, et al.

Leukemia|October 17, 2003

Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - a Europe Against Cancer programJ Gabert, E Beillard, V H J van der Velden, et al.

Leukemia|February 9, 2007

Analysis of minimal residual disease by Ig/TCR gene rearrangements: guidelines for interpretation of real-time quantitative PCR dataV H J van der Velden, G Cazzaniga, A Schrauder, et al.

Leukemia|September 26, 2013

An intragenic ERG deletion is a marker of an oncogenic subtype of B-cell precursor acute lymphoblastic leukemia with a favorable outcome despite frequent IKZF1 deletionsE Clappier, M F Auclerc, J Rapion, et al.

Leukemia|October 14, 2006

Allogeneic stem cell transplantation improves the outcome of adults with t(1;19)/E2A-PBX1 and t(4;11)/MLL-AF4 positive B-cell acute lymphoblastic leukemia: results of the prospective multicenter LALA-94 studyN Vey, X Thomas, C Picard, et al.

Leukemia|July 10, 2009

PAX5 mutations occur frequently in adult B-cell progenitor acute lymphoblastic leukemia and PAX5 haploinsufficiency is associated with BCR-ABL1 and TCF3-PBX1 fusion genes: a GRAALL studyJ Familiades, M Bousquet, M Lafage-Pochitaloff, et al.

Leukemia|May 4, 2007

Characterization of a reference material for BCR-ABL (M-BCR) mRNA quantitation by real-time amplification assays: towards new standards for gene expression measurementsJ Saldanha, M Silvy, N Beaufils, et al.

Leukemia|March 13, 2019

Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph + ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1H Pfeifer, G Cazzaniga, V H J van der Velden, et al.

Leukemia|January 16, 2020

Correction: Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1H Pfeifer, G Cazzaniga, V H J van der Velden, et al.

Pageof 6